Purpose of review The purpose of this review is to summarize the role of endothelial shear stress in the natural history of coronary atherosclerosis, and to propose an individualized riskstratification strategy of atherosclerotic lesions based on the in-vivo characterization of local endothelial shear stress and wall morphology.
Introduction
Atherosclerosis is a chronic inflammatory, fibroproliferative disease primarily of large and medium-sized conduit arteries, whose clinical manifestations constitute the primary cause of morbidity and mortality in the industrialized world [1] . Despite the systemic nature of atherosclerosis, its distribution is multifocal and heterogeneous, such that multiple atherosclerotic lesions at a different stage of progression coexist in the same individual, indeed, in the same artery at a single point in time [2, 3] . The significance of the multifocal and heterogeneous nature of coronary atherosclerosis is underscored by a recent 5-year follow-up study which demonstrated the development of new major cardiac events in almost 40% of patients in portions of the coronary arteries that were not perceived to exhibit atherosclerosis of sufficient severity to warrant revascularization at the time of an index procedure for another artery (Fig. 1) [4] .
Although all the coronary artery lesions are exposed to the same systemic risk factors, each of these atherosclerotic lesions presents its own potential for progression and risk. A portion of atherosclerotic lesions are thin cap fibroatheromas (TCFAs; also called high-risk or thrombosis-prone or vulnerable plaques) prone to acute disruption, and consequent acute coronary syndrome (Fig. 2a) . Histopathology studies by Virmani et al. indicate that more than 75% of TCFAs obstruct the coronary lumen by less than 50% prior to rupture, and do not limit coronary flow nor produce angina [5, 6 ]. These lesions are currently neither identified nor treated before plaque rupture. Even though we know that atherosclerotic lesions preferentially develop in regions of low endothelial shear stress (ESS) [7, 8] , the critical question is why only few among many individual local plaques rupture and lead to acute coronary syndrome (Fig. 2b) . The magnitude of low ESS is likely to be a critical determinant of the individual natural history of atherosclerotic lesions [9 ] .
The purpose of this review is to summarize the role of ESS in the natural history of coronary atherosclerosis, and to propose an individualized risk-stratification strategy of atherosclerotic lesions based on the in-vivo characterization of local ESS and wall morphology. Knowledge of the local ESS environment of a given plaque, in combination with the individual histopathologic characteristics of that plaque, and the nature of the vascular remodeling response may be essential in predicting the location and rate of atherosclerosis progression, and may help predict specific sites of plaque rupture by identifying lesions evolving toward vulnerability. Early identification of lesions, which are likely to evolve to high-risk plaque may justify more intensive systemic treatment or local interventions prior to plaque rupture.
Definition of endothelial shear stress and endothelial shear stress patterns ESS is the tangential stress derived from the friction of the flowing blood on the endothelial surface of the arterial wall [9 ,10] (Fig. 3a) . The pulsatile nature of the coronary blood flow in combination with the blood's rheological properties and the complex geometric configuration of the coronary arteries determines the ESS patterns, which are characterized by direction and magnitude (Fig. 3b ) [9 ,11,12] . In relatively straight arterial segments, ESS is pulsatile and unidirectional with a magnitude that varies within a range of 15-70 dyne/cm 2 over the cardiac cycle and yields a positive time-average.
In contrast, in geometrically irregular regions, where disturbed laminar flow occurs, pulsatile flow generates low or oscillatory ESS. Low ESS refers to ESS, which is unidirectional at any given point with a fluctuating magnitude during the cardiac cycle that results in a significantly low time-average (<10-12 dyne/cm 2 ) Beyond 1 year after implementation of bare metal stent a substantial number of events occurs due to nonstented lesions, whereas the event rate attributed to the stented target-lesions remains relatively stable and low. These findings confirm the multifocal and heterogeneous nature of coronary atherosclerosis. Adapted with permission [4] . ( Fig. 3b) [13] . Low ESS typically occurs at the inner areas of curvatures, as well as upstream of stenoses.
Oscillatory ESS is characterized by significant changes in both direction (i.e. it is bidirectional) and magnitude between systole and diastole, resulting in a very low time-average, usually close to zero (Fig. 3b) . Oscillatory ESS occurs primarily downstream of stenoses, at the lateral walls of bifurcations and in the vicinity of branch points. Beside the temporal oscillations, ESS exhibits significant spatial oscillations over short distances, especially in geometrically irregular regions, resulting in high spatial gradients, which are also involved in atherosclerosis [14, 15 ].
Role of endothelial shear stress in endothelial gene expression
Endothelial cells are capable of sensing the local ESS stimuli through several types of mechanoreceptors, located on the luminal, junctional and basal endothelial surfaces [9 ,16] . Following activation of mechanoreceptors, a complex network of intracellular pathways is activated, a process known as mechanotransduction (presented in detail in Fig. 4) [9 ,17] . These pathways lead to phosphorylation of several transcription factors, which in turn bind positive or negative shear stress responsive elements at promoters of mechanosensitive genes, inducing or suppressing gene expression, and ultimately modulating cellular function and morphology [7] . In arterial regions with nondisturbed flow, where ESS varies within a physiologic range, endothelial cells express various atheroprotective genes, and suppress several pro-atherogenic ones, leading eventually to stability and quiescence in that region. In contrast, in regions with low and disturbed flow where low or oscillatory ESS occur, the atheroprotective genes are suppressed, while the pro-atherogenic genes are upregulated, thereby promoting the atherosclerotic process [18, 19] .
Role of low endothelial shear stress in the pathophysiology of atherosclerosis
The role of ESS in the pathophysiology of atherosclerosis is summarized in Fig. 5 . In arterial regions with disturbed flow, low ESS reduces the bioavailability of nitric oxide by decreasing endothelial nitric oxide synthase mRNA and protein expression [20, 21 ], while upregulating endothelin-1 [22] , a potent vasoconstrictive and mitogenic molecule, thereby inducing endothelial dysfunction and exposing the endothelium to the atherogenic effect of local and systemic risk factors. Low ESS also promotes low-density lipoprotein-cholesterol (LDL-C) uptake and synthesis by the endothelium through upregulation of specific transcription factors, primarily sterol regulatory elements binding proteins, leading to subendothelial accumulation of LDL-C [23] . The increased mitotic and apoptotic activity of endothelial cells induced by the local low ESS [24] , as well as the conformational changes of endothelial cells from fusiform to polygonal shape [25] promote the widening of the junctions between endothelial cells, thereby accentuating the subendothelial deposition of LDL-C. Within the intima LDL-C is associated with proteoglycans [26 ] and undergoes oxidative modification by the increased reactive oxygen species (ROS). Low ESS mediates the production of ROS within the intima by enhancing gene expression and posttranscriptional activity of the major oxidative enzymes (i.e. nicotinamide adenine dinucleotide phosphate oxidase and xanthine oxidase) at endothelial cell membranes [27] . Low ESS also downregulates the intracellular ROS scavengers, such as manganese superoxide dismutase and glutathione, further augmenting local oxidative stress [18] . The minimal intimal accumulations of oxidized LDL-C constitute the earliest histopathologic stage of atherosclerosis, so-called fatty streaks (Fig. 6) [26 ,28] . Through activation of nuclear factor-k B (NF-kB) low ESS upregulates the expression of several adhesion molecules, such as vascular cell adhesion molecule-1, intercellular adhesion molecule-1 and E-selectin; chemoattractant chemokines, such as monocyte chemoattractant protein-1; and pro-inflammatory cytokines, such as tumor necrosis factor-a, interleukin-1, and interferon-g [29 ,30] . Adhesion molecules are expressed by endothelial cells and mediate the rolling and adhesion of circulating leukocytes (e.g. monocytes, T-cells, mast cells) on the endothelial surface, whereas monocyte chemoattractant protein-1 and other chemoattractant chemokines promote transmigration of leukocytes into the intima [1] . Local inflammatory cell accumulation is further enhanced by low ESS through upregulation of bone morphogenic protein-4, a member of the transforming growth factor-b (TGF-b) superfamily of cytokines [31] . Once monocytes infiltrate beneath the endothelium they undergo structural and functional alterations and differentiate to macrophages, which express scavenger receptors (CD36), phagocytize the oxidized LDL-C and transform to foam cells. Foam cells produce cytokines, growth factors [e.g. platelet-derived growth factor (PDGF)], ROS (e.g. myeloperoxidase) and matrix degrading enzymes [e.g. matrix metalloproteinases (MMPs), cathepsins], sustaining the local inflammation, oxidative stress, dynamic matrix remodeling, and ultimately atherosclerosis progression [1] . Overexpression and increased activity of MMPs, particularly MMP-2 and 9, and cathepsins (e.g. cathepsins K, L), which are the major proteases associated with extracellular matrix (ECM) degradation, are also mediated directly by low ESS, probably through NF-kB-dependent pathways [32 ,33,34 ,35 ]. The accumulations of lipid-laden foam cells constitute the intermediate lesions or pathologic intimal thickening, which evolve through several stages of progression (Fig. 6) [26 ] .
A portion of intermediate lesions, at some point during their natural history, acquire a fibrous cap and evolve to early fibroatheromas. Although the pathophysiologic events occurring during the transition of intermediate lesions to early fibroatheromas are not well understood, it appears that the regional disruption of the internal elastic lamina (IEL), which separates the diseased Risk stratification Chatzizisis et al. 555
Figure 4 Mechanotransduction of endothelial shear stress
Local endothelial shear stress (ESS) is sensed by luminal endothelial mechanoreceptors, such as ion channels, G-proteins, caveolae, tyrosine kinase receptors (TKRs), nicotinamide adenine dinucleotide phosphate (NADPH) oxidase and xanthine oxidase (XO), plasma membrane lipid bilayer, and heparan sulfate proteoglycans. Also, ESS signals are transmitted through the cytoskeleton to the basal or junctional endothelial surface, where certain integrins or a mechanosensory complex consisting of platelet endothelial cell adhesion molecule-1 (PECAM-1) and Flk-1 are activated, respectively, and initiate a downstream signaling cascade. Activated integrins phosphorylate and activate a multiple complex of nonreceptor tyrosine kinases (FAK, c-Src, Shc, paxillin, and p130CAS), adaptor proteins (Grb2, Crk), and guanine nucleotide exchange factors (Sos, C3G), thereby activating Ras family GTPase. Active Ras plays a pivotal role in intracellular transduction of ESS signals as it triggers various parallel downstream cascades of serine kinases; each of these kinases phosphorylates and hence activates the next one downstream, ultimately activating mitogen-activated protein kinases (MAPKs). Also, integrins promote the activation of Rho family small GTPases, which mediate the remodeling of cytoskeleton resulting in permanent structural changes of endothelial cells. Beside integrin-mediated mechanotransduction, ESS activates a number of other downstream signaling pathways initiated by luminal or junctional mechanoreceptors. These pathways include the production of reactive oxygen species (ROS) from NADPH oxidase and XO, activation of protein kinase C (PKC), release of endothelial nitric oxide synthase (eNOS) and other signaling molecules from caveolae, and activation of phosphoinositide-3 kinase (PI3K)-Akt cascade. Ultimately, all these signaling pathways lead to phosphorylation of several transcription factors (TFs), such as nuclear factor-kappa B (NF-kB) and activator protein-1 (AP-1). These TF proteins bind positive or negative shear stress responsive elements (SSREs) at promoters of mechanosensitive genes inducing or suppressing their expression, thereby modulating cellular function and morphology. Reprinted with permission [9 ] .
intima from the media, constitutes the key event that drives the formation of fibroatheromas. Histopathology studies in a diabetic, hyperlipidemic swine model of native atherosclerosis have shown that in the setting of very low levels of local ESS, and subsequently intense accumulation of inflammatory cells within the intima, the part of the IEL beneath the plaque undergoes local degradation by the foam cell-derived proteases (e.g. MMP-2, 9 and cathepsins) [36 ,37 ] . These IEL breaks constitute the gateway for vascular smooth muscle cells (VSMCs), which are originally located into the media, to enter the intima (Fig. 7a) [38 ,39] . Low ESS further promotes VSMC migration to the intima by enhancing the endothelial gene and protein expression of growth promoters, such as PDGF, endothelin-1, and vascular endothelial growth factor (VEGF) [32 ] , and blunting the expression of growth inhibitors, such as nitric oxide, TGF-b, and plasminogen activator inhibitor-1 [9 ] . Within the intima the VSMCs differentiate to a more synthetic phenotype to elaborate ECM proteins (e.g. collagen and elastin), and proliferate under the effect of growth factors secreted by endothelial cells and foam cells, thereby promoting plaque progression. The VSMCs, for yet unknown reasons, encompass the core of the lipid-laden foam cells (lipid core), produce ECM and create the fibrous cap, separating the thrombogenic lipid material from the circulating platelets and other pro-thrombotic factors. The fibrous cap along with the underlying lipid core forms the early fibroatheroma (AHA type IV lesion) [28, 40] .
A second key factor, in addition to IEL degradation, that critically determines the natural history of atherosclerosis is neovascularization (angiogenesis). Dense neovessels developed within the atherosclerotic plaque from the existing adventitial vasa vasorum supply the lesion with LDL-C, inflammatory cells, ROS and matrix proteases from the 'back door', thereby reinforcing the inflamed status of the plaque and promoting plaque progression [41 ,42] . Strong support for an active role of angiogenesis in the natural history of atherosclerosis is provided by studies which showed that inhibition of neovascularization prevents the progression of atherosclerotic lesions [43] . Low ESS facilitates intimal neovascularization by inducing intimal thickening and thus ischemia, upregulating the expression of VEGF and other angiogenic factors [19] , enhancing local inflammation, oxidative stress, and expression of matrix degrading enzymes, and accentuating endothelial cell and VSMC migration and proliferation.
Low endothelial shear stress modulates the natural history of atherosclerotic plaques Following their formation early fibroatheromas follow an individualized natural history, which is critically dependent on the balance of two competing processes:
In arterial regions with disturbed laminar flow, low endothelial shear stress (ESS) shifts the endothelial function and structure toward an atherosclerotic phenotype, thereby promoting atherogenesis, atherosclerotic plaque formation and progression, and vascular remodeling. BMP, bone morphogenic protein; ET, endothelin; eNOS, endothelial nitric oxide synthase; ICAM, intercellular adhesion molecule; IFN, interferon; IL, interleukin; LDL, low-density lipoprotein cholesterol; MCP, monocyte chemoattractant protein; MMP, matrix metalloproteinase; NO, nitric oxide; PDGF, platelet-derived growth factor; ROS, reactive oxygen species; SREBP, sterol regulatory element binding protein; TF, transcription factor; TGF, transforming growth factor; TNF, tumor necrosis factor; t-PA, tissue plasminogen activator; VCAM, vascular cell adhesion molecule; VEGF, vascular endothelial growth factor; VSMC, vascular smooth muscle cell. Reprinted with permission [9 ] .
inflammation with concomitant ECM degradation versus fibroproliferation with ECM synthesis. Experimental histopathology studies in a diabetic, hyperlipidemic swine model of native atherosclerosis showed that the magnitude of low ESS is a key regulator of the balance between inflammation/ECM degradation and fibroproliferation/ECM synthesis, thereby determining the remodeling response of the vascular wall to the growing plaque [36 ,37 ,44 ] . A portion of early fibroatheromas will evolve into high-risk plaques, whereas others will remain quiescent and still others will evolve to fibrous stenotic plaques [9 ] (Fig. 8) .
High-risk plaques
High-risk plaques are typically TCFAs, characterized by a thin, highly inflamed fibrous cap overlying a large necrotic lipid core, rich in neovessels [28] (Figs 2 and 8 ). These plaques are usually minimally stenotic lesions associated with expansive vascular remodeling, and an increased risk of sudden rupture that precipitates 60-70% of acute coronary syndromes [28, [45] [46] [47] . Experimental studies showed that TCFAs develop in arterial areas with the lowest values of ESS, which enhance plaque inflammation, especially at the base of the plaque [36 ,37 ] . In this setting, the underlying IEL undergoes severe degradation (Fig. 7b) , the media becomes severely inflamed and acquires the enzymatic products that shift the ECM balance towards intensive degradation, thereby promoting excessive (aneurysm-like) wall expansion and accommodation of the enlarging plaque [48 ] . Excessive expansive remodeling leads to perpetuation, or even exacerbation, of the local low-ESS environment, thereby fostering continued lipid accumulation and inflammation, which lead to additional matrix protease expression, intensive matrix degradation within the inflamed vascular wall and the fibrous cap shoulders, additional wall expansion and fibrous cap thinning. This self-perpetuating vicious cycle among low local ESS, inflammation, and excessive expansive remodeling exacerbates the inflammatory status of the plaque and may rapidly transform an early fibroatheroma to a TCFA.
The presence and severity of systemic factors (e.g. magnitude of hyperlipidemia, hyperglycemia, hypertension), as well as genetic factors also interplay with the low-ESS microenvironment and modulate the excessive expansion of the arterial wall.
Quiescent plaques
A portion of early fibroatheromas evolve to quiescent plaques, which are nonstenotic or minimally stenotic lesions with a thick fibrous cap and a small lipid core (Fig. 8) . These plaques are characterized by limited inflammation, remain biologically quiescent, and cause no symptoms [49] . Quiescent lesions appear to develop in arterial regions with slightly low ESS and do not acquire the severity of lipid accumulation and inflammation, as do areas with lower ESS in which TCFAs develop; hence a stable balance between inflammation and fibroproliferation is established [36 ,37 ] . As a result of the limited inflammation that is stimulated, the IEL degradation and Risk stratification Chatzizisis et al. 559
Figure 8 Proposed natural history of coronary atherosclerosis
The initiating process of atherosclerosis in an atherosclerosis-prone region is a low-endothelial-shear-stress (ESS) environment, leading to the formation of an early fibroatheroma. The magnitude of low ESS, the severity of plaque inflammation and the vascular remodeling response to the presence of the plaque are key regulators of the subsequent natural history of the fibroatheroma. In regions with very low ESS plaque inflammation is exacerbated and promotes severe degradation of the internal elastic lamina (IEL) at the base of the plaque. In this setting, the media becomes severely inflamed and acquires the enzymatic products that shift the extracellular matrix balance towards intensive degradation, thereby promoting excessive (aneurysm-like) wall expansion and accommodation of the enlarging plaque. Excessive expansive remodeling leads to perpetuation, or even exacerbation, of the local low-ESS environment, thereby fostering continued lipid accumulation and inflammation, which lead to additional matrix protease expression, intensive matrix degradation within the inflamed vascular wall and the fibrous cap shoulders, additional wall expansion and fibrous cap thinning. This selfperpetuating vicious cycle among low local ESS, inflammation, and excessive expansive remodeling exacerbates the inflammatory status of the plaque and may rapidly transform an early fibroatheroma to a thin cap fibroatheroma. In arterial regions with slightly low ESS the severity of lipid accumulation and inflammation is limited and subsequently the IEL degradation and wall expansion are limited. In this setting, the growing plaque slightly narrows the lumen (i.e. compensatory expansive remodeling), thereby restoring the adverse ESS stimulus to less pathologic levels and establishing quiescence. Fibrous stenotic plaques either directly evolve with a phenotype promoting fibroproliferation consistently throughout their natural history course, or represent an end-stage of scarring in the setting of prior inflamed thin cap fibroatheromas through repetitive microruptures and subsequent healing. Stenotic plaques are associated with constrictive remodeling and infrequently undergo local erosion, which leads to local thrombus formation and precipitation of an acute coronary syndrome. Reprinted with permission [9 ] .
wall expansion are limited. The growing plaque leads to limited enlargement of the vessel wall and then starts to slightly protrude into the lumen (i.e. compensatory expansive remodeling), thereby restoring the adverse low-ESS stimulus to higher, less pathologic, levels [37 ,50] . In the setting of the attenuated low-ESS stimulus for exacerbation of inflammation, plaque progression and arterial expansion, the inflammatory process is limited and quiescence is established.
The long-term stability or quiescence of these plaques, however, is unknown. If local vascular conditions later change, such that a low ESS microenvironment is recreated, or the systemic atherosclerotic stimuli are enhanced (e.g. increased magnitude of hyperlipidemia), then the process of inflammation, progressive atherosclerosis, and excessive expansive remodeling may again re-emerge, and may transform the quiescent lesion to a TCFA.
Fibrous plaques
Stenotic plaques are stable fibroproliferative lesions with limited inflammation, characterized morphologically by a relatively thick, collagen-rich fibrous cap, overlying a small lipid core [28, 46] (Fig. 8) . These lesions are associated with constrictive vascular remodeling, and over time become occlusive, resulting in chronic stable angina. Many stenotic lesions represent an end-stage of scarring in the setting of prior inflamed TCFA undergoing repetitive microruptures, VSMC proliferation, local deposition of collagen and subsequent healing [51] . Stenotic lesions may also directly evolve from early fibroatheromas with a phenotype promoting fibroproliferation versus inflammation throughout its natural history course [52 ] . The pathophysiologic factors involved in this process are currently unknown.
Stenotic plaques infrequently undergo local erosion or develop calcified nodules, which lead to local thrombus formation precipitating 20-40% of acute coronary syndromes [28] . Low ESS does not appear to play a role in the pathophysiology of plaque erosion. High ESS, however, which occurs at the throat of highly stenotic plaques, may be responsible for local endothelial erosion and induction of acute coronary thrombosis.
Risk stratification of individual atherosclerotic lesions
Given the marked heterogeneity of natural history trajectories of coronary atherosclerosis, development of a comprehensive approach for risk stratification of each individual plaque at early stages would be invaluable. The major characteristics of individual atherosclerotic plaques contributing to the ongoing process of the respective natural history trajectories include the magnitude of ESS, which constitutes the stimulus for ongoing inflammation and plaque progression, the severity of inflammation that plaque acquires over its development and progression, and the nature of vascular remodeling response to the presence of the plaque; both the magnitude of inflammation and the vascular remodeling response are directly determined by the local ESS environment. Measurement of local ESS, complemented by the assessment of the severity of inflammation and vascular remodeling at early stages of the natural history of a given lesion, would allow for detailed risk stratification of that lesion to evolve to high-risk plaque based on the following conceptual scheme (Fig. 9): (1) high-risk early lesion with very low ESS, intense inflammation and excessive expansive remodeling; (2) medium-risk early lesion with low/moderate ESS, moderate inflammation and less excessive expansive remodeling; (3) low-risk early lesion with physiologic ESS, limited inflammation and compensatory expansive remodeling.
Integration into the above scheme of patient-specific systemic characteristics (e.g. magnitude of hyperlipidemia), as well as of the information provided by traditional and novel systemic biomarkers (e.g. high sensitivity C-reactive protein, lipoprotein-associated phospholipase A 2 ) [53 ,54 ] and genomics [55 ] would increase our ability to predict the future natural history of individual plaques. The ability, however, of such stratification strategies to predict the clinical outcomes needs to be tested in the clinical arena. Several natural history studies are now underway [56 ] ; a large natural history study in patients with coronary artery disease (PREDICTION Trial) investigates the incremental value of characterizing the local ESS and remodeling environment to predict the development of new acute cardiac events. Several in-vivo technologies for the assessment of functional and morphologic characteristics of a particular plaque now exist, including intravascular ultrasound (IVUS)-based virtual histology and palpography, thermography, optical coherence tomography, near-infrared spectroscopy, intravascular magnetic resonance imaging, and angioscopy [56 ] . Although these modalities may be useful to characterize a particular plaque, they may be insufficient to optimally predict future risk because they provide a snapshot of the plaque at only a single point in time. Thus, these modalities are most useful to identify only the ends of the spectrum between a stenotic plaque and a high-risk plaque, but they cannot address the stimuli responsible for the subsequent natural history of that plaque. Incorporation of an in-vivo assessment of local ESS stimuli and local remodeling behavior of a particular plaque may substantially enhance the prognostic significance of these imaging modalities because one can then have insight into both the existing nature and the future natural history of that plaque. Technologies now exist for in-vivo assessment of ESS. The most comprehensive technique for investigating the relationship between ESS and vascular pathobiology is a methodology known as vascular profiling [13] , a highly accurate [57 ,58
,59] and reproducible [60] imaging technique, which utilizes routine IVUS and coronary angiography to create an accurate three-dimensional representation of the coronary artery (Fig. 10 ). Computational fluid dynamics is then used to determine the flow patterns within the artery, which in turn form the basis of identifying both the magnitude of local ESS and vascular remodeling behavior within a given arterial subsegment. Future technologies may be able to noninvasively assess local ESS and remodeling behavior with multislice computed tomography [61 ] , magnetic resonance imaging [62] , or other imaging approaches.
Molecular imaging for assessment of inflammation
As a potential aid for the direct assessment of the severity of plaque inflammation new molecular imaging nanotechnologies have been developed within the last few years (Fig. 11) . Molecular imaging of inflammation in atherosclerosis is an emerging field that is based on the strategy that certain molecular imaging agents (tracking agents) carry an affinity ligand (e.g. peptide, engineered antibody, or other small molecules), which binds specific molecular mediators of inflammation within the plaque (e.g. VCAM-1) [63 -66 ] . Using appropriate, preferably noninvasive, molecular imaging systems, such as magnetic resonance imaging [63 ] , computed tomography [64 ] , ultrasound [65 ] , nuclear imaging [66 ], or optical imaging [63 ] , the tracking agents are detected and the Risk stratification Chatzizisis et al. 561 signal intensity, and indirectly the magnitude of inflammation, are assessed.
Lesion-specific therapeutic opportunities
Risk stratification of early atherosclerotic lesions and identification of their subsequent natural history may permit the development of novel lesion-specific therapeutic strategies. Identification of a high-risk plaque at its early stages of development would potentially justify highly selective, prophylactic local interventions, such as implantation of stents or targeted nanoparticle-based delivery of anti-inflammatory drugs, supplemented by an intensive systemic pharmacologic approach to limit the severity of inflammation, stabilize the plaque, and therefore avert a future acute coronary event. Newer stents associated with reduced rates of late thrombosis and other complications are anticipated to contribute substantially towards this direction. Application of less aggressive strategies, such as moderate antiatherosclerotic therapies combined with regular follow-up, could be justified for early lesions with the potential to evolve to quiescent plaques. The clinical and economic implications of identifying and treating high-risk individual coronary lesions before an adverse cardiac event can occur are anticipated to be enormous.
Conclusion
The magnitude of low ESS is a critical factor that determines the severity of inflammation within a given early atherosclerotic plaque, and subsequently the nature of vascular remodeling response and the individual natural history of that plaque. In the setting of very low ESS plaque inflammation is intense, the artery undergoes local excessive expansive remodeling and the lesion evolves to high-risk plaque. In the setting of slightly low ESS the inflammation is limited, the artery undergoes compensatory expansive remodeling, which restores the local ESS to less pathologic levels, and the plaque remains quiescent. In-vivo assessment of the local ESS environment, the severity of inflammation and the vascular remodeling response, in combination with the information provided by systemic biomarkers of vulnerability, may allow for detailed risk stratification of individual early coronary plaques, thereby guiding both systemic and local, preemptive, lesion-specific therapeutic strategies. Current imaging techniques have the potential to enable risk stratification of early plaque and predict the progression to high-risk plaque. Future natural history studies will clarify whether prediction of progression of vulnerability, culminating in plaque rupture, can be accomplished.
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